financetom
Business
financetom
/
Business
/
TopBuild's Q1 Adjusted Earnings, Revenue Increase; Authorizes $1 Billion Share Buyback
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TopBuild's Q1 Adjusted Earnings, Revenue Increase; Authorizes $1 Billion Share Buyback
May 7, 2024 4:59 AM

07:36 AM EDT, 05/07/2024 (MT Newswires) -- TopBuild ( BLD ) reported Q1 adjusted earnings Tuesday of $4.81 per diluted share, up from $4.36 a year earlier.

Analysts polled by Capital IQ expected $4.56.

Revenue for the quarter ended March 31 was $1.28 billion, up from $1.27 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.30 billion.

The company increased its full-year 2024 revenue outlook to $5.4 billion to $5.6 billion. That compares with $5.36 billion to $5.56 billion previously. Analysts surveyed by Capital IQ expect $5.50 billion.

The company said its board has authorized the repurchase of up to $1 billion of its outstanding common stock. The new authorization brings the total availability for share repurchases to $1.15 billion, the company said.

Price: 430.10, Change: +12.53, Percent Change: +3.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Insight Molecular Says GraftAssure Assay Helped Avoid Overtreatment in Kidney Transplant Patient
Insight Molecular Says GraftAssure Assay Helped Avoid Overtreatment in Kidney Transplant Patient
Oct 6, 2025
08:28 AM EDT, 10/06/2025 (MT Newswires) -- Insight Molecular Diagnostics ( IMDX ) shares were over 10% higher premarket Monday after the company said its GraftAssure assay helped avoid overtreatment for a kidney transplant patient who developed a type of lymphoma. The biotech company said the 33-year-old transplant patient had to end traditional immunosuppression for treatment and that GraftAssure molecular...
Market Chatter: AstraZeneca Signs $555 Million Deal With Algen
Market Chatter: AstraZeneca Signs $555 Million Deal With Algen
Oct 6, 2025
08:19 AM EDT, 10/06/2025 (MT Newswires) -- AstraZeneca ( AZN ) has signed a $555 million deal with Algen Biotechnologies to develop gene-editing therapies using artificial intelligence, the Financial Times reported Monday. Under the deal, AstraZeneca ( AZN ) will gain exclusive rights to develop and commercialize therapies from the Crispr gene-editing technology, and Algen will receive up to $555...
Blackstone, Abu Dhabi's Lunate team up to invest $5 billion in Gulf logistics
Blackstone, Abu Dhabi's Lunate team up to invest $5 billion in Gulf logistics
Oct 6, 2025
DUBAI, Oct 6 (Reuters) - Blackstone and Abu Dhabi's Lunate plan to set up a platform that will target investments in logistics assets in the Gulf region worth $5 billion, the two alternative investment managers said in a statement on Monday. Under a strategic partnership, the GLIDE platform will target high-quality warehouse assets, targeting mainly greenfield developments and focusing on...
NanoXplore Said Received up to $2.75 Million Contribution from the Govt of Canada
NanoXplore Said Received up to $2.75 Million Contribution from the Govt of Canada
Oct 6, 2025
08:23 AM EDT, 10/06/2025 (MT Newswires) -- NanoXplore ( NNXPF ) , a global graphene company, announced Monday that it has received a contribution of up to $2.75 million from the Government of Canada under the Energy Innovation Program (EIP). In a statement it said this support will help advance the development of ultra high-power cylindrical format lithium-ion cells for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved